{"ticker": {"uuid": "c5520ee0-6aa5-4c47-9f7e-8d388a3694c6", "symbol": "688180", "name": "Shanghai Junshi Biosciences Co., Ltd.", "exchange": "SHH", "country": "CN", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Shanghai Junshi Biosciences Co., Ltd. Receives Acceptance Of Supplemental Application For Toripalimab In Combination With Chemotherapy As Perioperative Treatment For Resectable Stage II-III NSCLC Patients", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxNM1ZxejYxRV9RZE1EWm5zSHpjRzgyXzczblhQelFyQS1haWpSamhlWlpySUJPTGhfN0NRMFBOVDJNeU5tYnlZeEtuZzBlTkFtOC15cUtrWjktaEc3cktBQUNyZWZwb3I2UWUxMk1BUjJ5am43Mmt2LWR3UGQ2TnRWRFNIMEJwcDJQaUxaaDF1UmJkdThZNHl3WEQ3LUJXY2I1NDNYLWZyZ2otVlptVWV5QkdUblM1VnhueEl3cWZPbDZwb1FuOFcwZEVWV2JlU0RBSzVqWURmNFdnNWtBTEJLSWRsLWo?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-21T14:35:26+00:00", "published_display": "21 Jul 2026 14:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Junshi Biosciences Wins NMPA Nod to Expand Toripalimab Use in Early-Stage Lung Cancer", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxNZENxcEwwR0RYTVpFcHoxc1U2REVDYjNqa1FvT1FjV2VYR21KdVFUX2VBSzVSMUxvUllOTkc3XzBLRVhsM2lOMW1PVGZENV83RHE3Smh2ajdSenZyVlVrMi1zdm8xelE2Vm9MUDhMaXFMSnFwY1l0TmJ2T1hmZkhWWUtCLThrNXljZlpyN1M2a0NrS2Q3VTliQmJOLVZtdTBTTlFYOGhTZFJVRG02RHNUZWdMWlUwangtZTlPTDFlVHFUZ0dQZTNPOHprU2l5bEtIUWVj?oc=5", "source_name": "TipRanks", "published_at": "2026-07-21T14:15:04+00:00", "published_display": "21 Jul 2026 14:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What's Driving Junshi Biosciences' Recent Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxORDJkaDFfajQ1MnJaR2Q5WDBrb25EZW5iOUc1aFV0bEtqUDlxeXNuVWtfcWVRQlBzdFRVTk9vTEVxS000amtBNWdiUW4yVjFHWWhFdnp0QlFCaHVaLUNuN20xSjY3dGVNdGEyNE1HeTN2cFhsN0k3UFMzVlhBZHNLaEh0SDg3R2FWTDZtNA?oc=5", "source_name": "Kavout | AI", "published_at": "2026-07-16T06:21:12+00:00", "published_display": "16 Jul 2026 06:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Junshi Biosciences", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNempsdTQwUjBhc0dwbGc4WkFvbV9GNmNYX3dqeURHaXpabU9HbmpZUXFxZ3YtY3M0QjRvR1l4Z1pfSnJfbFgwcUQ1NV9xeDZjNURoak5PcklZNWhOSEFFTnR2VGFNUnhEc0JJd0xXSTFXYWcwaTk0SERIcWQyQU0zd2c4ZU16bE5vVDZvc1ZaMmJxSlJSSDN3?oc=5", "source_name": "Via Ritzau", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shanghai Junshi Biosciences Co., Ltd. Appoints Chen Liang as Independent Non-Executive Director and Announces Change in Composition of Board Committees, Effective June 26, 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxPam9EcUZhVUhubTdELTFGOUFKYWdMTG84QjRvOEdXUXp3N2JQWEVUbkNHeGl0NVMwQW91MVgzNElfclFHbEEtSF80T0JMWmV4SjV2UWVFWnFuMFc3X2xvYVpHT0RvYm9TSjBlQ3hWekJIckVLclBDWmVGNnBxeEZneVdyUFJOSFZudjVpeTVNYnJiUnNjNDhPeXVVbFFyRjY2cTlPWFlucmZYR3FwSkpNc05FS1FpZmF5WnB4UUR6RXQ4cnlCcGs5UFpnVjJqSS1jV20xSWNDUy1EWXNyOWlQOWlPSQ?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shanghai Junshi Biosciences Co., Ltd. Intends to Enter into the Joint Venture Agreement with Suzhou Union Biopharm Co., Ltd, Shanghai Junshi Biotechnology Co., Ltd, Suzhou Junmeng Biosciences Co., Ltd, Shanghai Ontarget Biopharmaceuticals Co., Ltd a", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxQUG1iQ0NENXFWSlRnMFRTNGI1NndCc3VQSW9PTWZyY01Va1hBcllwVWtyODVKeG9aRUlvNm9nY0VLR2RMVXR1Ti1RWlpwNEZaMS0tS1Q0dVlrbjVfQkFPXzVsSjByUkpsS3F4R2txVVFGcy1kVUdtbXVOd3BqV1MxZm9DU0hlWmJiUEJ6SXJQM196TS10T2I5dURrTTBQZFloR0lLM0ZmSzhmSDNfMGVjbC00MElRWWRYa0RIR21CN1dzREJlYWVtLTZJdVBHSWVfVk1tb19WOElQNVFEWkNPb3dQZw?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Junshi Biosciences Announces Ongericimab\u2019s sNDA Approval in China", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPT3ZKWVVJRUpaRlktbURXNWQxMTNsRHhPTkE4YU04Rm1YMHFfQW5wNmpRcUlTTnA2RXVWUEZnZGFVV1hSNHpJUFZpellfcG5tSkM1ZmlzV3h1QW5aUEJPa3JUYjVoeXVrN0oxY2RlbW1BcEJMRVUzOEszbllNaFpoRjNiM0c5bURfZTI2eWFncWRDRTBYNnc?oc=5", "source_name": "Macau Business", "published_at": "2025-05-27T07:00:00+00:00", "published_display": "27 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Junshi Biosciences Aims to Raise $4.77 Million From International Share Sale", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOQ2wtUjd3cUZId3NHMHlralQxWDhTUUU4djdsSlcyMXBNLS1WSEdIeDJjZnhMNlc3ODI1cTB3UXFkTzU5NXp3a3RzMWVMV09CbmxZc3hwV2FpV3JBWWpISUNpXzNNZTBGMERsVDlzbEQtRjc2NWt6c3BHMUVvc25qSTNJalhaSC1BN0pTcDJOU0s2akJOS2ViYmZfMXh0S3c2eVNKcDhwTU5yem1xV1M5Q1VFWmdVWnhaMHlFenhla2RNVnRzT3JiSA?oc=5", "source_name": "Caixin Global", "published_at": "2023-06-07T07:00:00+00:00", "published_display": "07 Jun 2023 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shanghai Junshi Biosciences Co., Ltd. Class A Balance Sheet \u2013 SSE:688180", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE5qRWdDeklTaGg0QzdSbnRza09kdmpFczdzUUFMSkxxZlRaSGEtVmVxMXZwQXU5bUhJSE5XY3RWVTZqcjZ5bGQ5WVZsa1JHc1k5REtyR1RNR3N0YkUyZWZtM013eG0wZEVBN0Q1X2VtRTB3bEtJT25kYl93V3I?oc=5", "source_name": "TradingView", "published_at": "2021-04-21T07:32:10+00:00", "published_display": "21 Apr 2021 07:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "1877.HK - Shanghai Junshi Biosciences Co., Ltd. Company Profile", "summary": "", "url": "https://news.google.com/rss/articles/CBMiS0FVX3lxTE9GNTZoTzdVOVl3UXJrR0R4NjZQX0NaYXZ0U05MM09JVFhCMERHRm1Udmg4WjlRaXF5MUlzOUxWV1R4WE00aTB2aTF4QQ?oc=5", "source_name": "StockInvest.us", "published_at": "2020-08-13T09:26:17+00:00", "published_display": "13 Aug 2020 09:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shanghai Junshi Biosciences soars over 22% on HK debut | Gulf Times", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPUTdGUVdHQTRPRG1pOXBMYlgtbWNad3BsMEl1c3Q3ejhSb3VwYmtzM2tSbnh1Z252aGs2TVR4LUdDSGFiVWRjUmVpZmFwQkl4M2pjREhNM0VaamlBVWZOX0t3NE1hbXVNMzRPTW9idWQzZ01zeFdyTEV4TkpzTmlpeXllUWNNLUFYQ3c0TXpHMGtNU1lWSDE2QtIBngFBVV95cUxPNFhTck5QbXlDUEpoLTNQdVJ2cS16ejVqb2FjTVpJX3NSMUk5SW9WdG5KdVFDZElCOFFWSUljWVNaZTgzMW1IWkxLRVpDdEFmTWhUU2Mxd3hraTBqNUQ3UkxSSVhHNmRoT1VUdzFtakJPaG1PRTRvaUo3bU5rNmlCaHlnZzdMcFNwNVE3c3k0V1JZV29TRjdkdlNpOFlsUQ?oc=5", "source_name": "Gulf Times", "published_at": "2018-12-24T08:00:00+00:00", "published_display": "24 Dec 2018 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Shanghai Junshi Biosciences Co., Ltd. Receives Acceptance Of Supplemental Application For Toripalimab In Combination With Chemotherapy As Perioperative Treatment For Resectable Stage II-III NSCLC Patients", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxNM1ZxejYxRV9RZE1EWm5zSHpjRzgyXzczblhQelFyQS1haWpSamhlWlpySUJPTGhfN0NRMFBOVDJNeU5tYnlZeEtuZzBlTkFtOC15cUtrWjktaEc3cktBQUNyZWZwb3I2UWUxMk1BUjJ5am43Mmt2LWR3UGQ2TnRWRFNIMEJwcDJQaUxaaDF1UmJkdThZNHl3WEQ3LUJXY2I1NDNYLWZyZ2otVlptVWV5QkdUblM1VnhueEl3cWZPbDZwb1FuOFcwZEVWV2JlU0RBSzVqWURmNFdnNWtBTEJLSWRsLWo?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-21T14:35:26+00:00", "published_display": "21 Jul 2026 14:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Junshi Biosciences Wins NMPA Nod to Expand Toripalimab Use in Early-Stage Lung Cancer", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxNZENxcEwwR0RYTVpFcHoxc1U2REVDYjNqa1FvT1FjV2VYR21KdVFUX2VBSzVSMUxvUllOTkc3XzBLRVhsM2lOMW1PVGZENV83RHE3Smh2ajdSenZyVlVrMi1zdm8xelE2Vm9MUDhMaXFMSnFwY1l0TmJ2T1hmZkhWWUtCLThrNXljZlpyN1M2a0NrS2Q3VTliQmJOLVZtdTBTTlFYOGhTZFJVRG02RHNUZWdMWlUwangtZTlPTDFlVHFUZ0dQZTNPOHprU2l5bEtIUWVj?oc=5", "source_name": "TipRanks", "published_at": "2026-07-21T14:15:04+00:00", "published_display": "21 Jul 2026 14:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What's Driving Junshi Biosciences' Recent Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxORDJkaDFfajQ1MnJaR2Q5WDBrb25EZW5iOUc1aFV0bEtqUDlxeXNuVWtfcWVRQlBzdFRVTk9vTEVxS000amtBNWdiUW4yVjFHWWhFdnp0QlFCaHVaLUNuN20xSjY3dGVNdGEyNE1HeTN2cFhsN0k3UFMzVlhBZHNLaEh0SDg3R2FWTDZtNA?oc=5", "source_name": "Kavout | AI", "published_at": "2026-07-16T06:21:12+00:00", "published_display": "16 Jul 2026 06:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Junshi Biosciences", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNempsdTQwUjBhc0dwbGc4WkFvbV9GNmNYX3dqeURHaXpabU9HbmpZUXFxZ3YtY3M0QjRvR1l4Z1pfSnJfbFgwcUQ1NV9xeDZjNURoak5PcklZNWhOSEFFTnR2VGFNUnhEc0JJd0xXSTFXYWcwaTk0SERIcWQyQU0zd2c4ZU16bE5vVDZvc1ZaMmJxSlJSSDN3?oc=5", "source_name": "Via Ritzau", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shanghai Junshi Biosciences Co., Ltd. Appoints Chen Liang as Independent Non-Executive Director and Announces Change in Composition of Board Committees, Effective June 26, 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxPam9EcUZhVUhubTdELTFGOUFKYWdMTG84QjRvOEdXUXp3N2JQWEVUbkNHeGl0NVMwQW91MVgzNElfclFHbEEtSF80T0JMWmV4SjV2UWVFWnFuMFc3X2xvYVpHT0RvYm9TSjBlQ3hWekJIckVLclBDWmVGNnBxeEZneVdyUFJOSFZudjVpeTVNYnJiUnNjNDhPeXVVbFFyRjY2cTlPWFlucmZYR3FwSkpNc05FS1FpZmF5WnB4UUR6RXQ4cnlCcGs5UFpnVjJqSS1jV20xSWNDUy1EWXNyOWlQOWlPSQ?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shanghai Junshi Biosciences Co., Ltd. Intends to Enter into the Joint Venture Agreement with Suzhou Union Biopharm Co., Ltd, Shanghai Junshi Biotechnology Co., Ltd, Suzhou Junmeng Biosciences Co., Ltd, Shanghai Ontarget Biopharmaceuticals Co., Ltd a", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxQUG1iQ0NENXFWSlRnMFRTNGI1NndCc3VQSW9PTWZyY01Va1hBcllwVWtyODVKeG9aRUlvNm9nY0VLR2RMVXR1Ti1RWlpwNEZaMS0tS1Q0dVlrbjVfQkFPXzVsSjByUkpsS3F4R2txVVFGcy1kVUdtbXVOd3BqV1MxZm9DU0hlWmJiUEJ6SXJQM196TS10T2I5dURrTTBQZFloR0lLM0ZmSzhmSDNfMGVjbC00MElRWWRYa0RIR21CN1dzREJlYWVtLTZJdVBHSWVfVk1tb19WOElQNVFEWkNPb3dQZw?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Junshi Biosciences Announces Ongericimab\u2019s sNDA Approval in China", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPT3ZKWVVJRUpaRlktbURXNWQxMTNsRHhPTkE4YU04Rm1YMHFfQW5wNmpRcUlTTnA2RXVWUEZnZGFVV1hSNHpJUFZpellfcG5tSkM1ZmlzV3h1QW5aUEJPa3JUYjVoeXVrN0oxY2RlbW1BcEJMRVUzOEszbllNaFpoRjNiM0c5bURfZTI2eWFncWRDRTBYNnc?oc=5", "source_name": "Macau Business", "published_at": "2025-05-27T07:00:00+00:00", "published_display": "27 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Junshi Biosciences Aims to Raise $4.77 Million From International Share Sale", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOQ2wtUjd3cUZId3NHMHlralQxWDhTUUU4djdsSlcyMXBNLS1WSEdIeDJjZnhMNlc3ODI1cTB3UXFkTzU5NXp3a3RzMWVMV09CbmxZc3hwV2FpV3JBWWpISUNpXzNNZTBGMERsVDlzbEQtRjc2NWt6c3BHMUVvc25qSTNJalhaSC1BN0pTcDJOU0s2akJOS2ViYmZfMXh0S3c2eVNKcDhwTU5yem1xV1M5Q1VFWmdVWnhaMHlFenhla2RNVnRzT3JiSA?oc=5", "source_name": "Caixin Global", "published_at": "2023-06-07T07:00:00+00:00", "published_display": "07 Jun 2023 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shanghai Junshi Biosciences Co., Ltd. Class A Balance Sheet \u2013 SSE:688180", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE5qRWdDeklTaGg0QzdSbnRza09kdmpFczdzUUFMSkxxZlRaSGEtVmVxMXZwQXU5bUhJSE5XY3RWVTZqcjZ5bGQ5WVZsa1JHc1k5REtyR1RNR3N0YkUyZWZtM013eG0wZEVBN0Q1X2VtRTB3bEtJT25kYl93V3I?oc=5", "source_name": "TradingView", "published_at": "2021-04-21T07:32:10+00:00", "published_display": "21 Apr 2021 07:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "1877.HK - Shanghai Junshi Biosciences Co., Ltd. Company Profile", "summary": "", "url": "https://news.google.com/rss/articles/CBMiS0FVX3lxTE9GNTZoTzdVOVl3UXJrR0R4NjZQX0NaYXZ0U05MM09JVFhCMERHRm1Udmg4WjlRaXF5MUlzOUxWV1R4WE00aTB2aTF4QQ?oc=5", "source_name": "StockInvest.us", "published_at": "2020-08-13T09:26:17+00:00", "published_display": "13 Aug 2020 09:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shanghai Junshi Biosciences soars over 22% on HK debut | Gulf Times", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPUTdGUVdHQTRPRG1pOXBMYlgtbWNad3BsMEl1c3Q3ejhSb3VwYmtzM2tSbnh1Z252aGs2TVR4LUdDSGFiVWRjUmVpZmFwQkl4M2pjREhNM0VaamlBVWZOX0t3NE1hbXVNMzRPTW9idWQzZ01zeFdyTEV4TkpzTmlpeXllUWNNLUFYQ3c0TXpHMGtNU1lWSDE2QtIBngFBVV95cUxPNFhTck5QbXlDUEpoLTNQdVJ2cS16ejVqb2FjTVpJX3NSMUk5SW9WdG5KdVFDZElCOFFWSUljWVNaZTgzMW1IWkxLRVpDdEFmTWhUU2Mxd3hraTBqNUQ3UkxSSVhHNmRoT1VUdzFtakJPaG1PRTRvaUo3bU5rNmlCaHlnZzdMcFNwNVE3c3k0V1JZV29TRjdkdlNpOFlsUQ?oc=5", "source_name": "Gulf Times", "published_at": "2018-12-24T08:00:00+00:00", "published_display": "24 Dec 2018 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 71, "total_relevant": 11, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 10, "score": 51, "total": 11, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 92, "events": [{"event": "general", "label": "Market update", "weight": 5.5, "count": 10}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 35.1, "latest_week": "2026-07-17", "one_week_move": -6.6, "four_week_move": 16.7, "twelve_week_move": -11.8, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.139475, "market_dynamics_buy_signal": false, "relative_strength": -2.558326, "fair_value_gap": 3.0, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 46.9466, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-6.6% over one week, +16.7% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 63, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "marketscreener.com", "count": 3}, {"label": "TipRanks", "count": 1}, {"label": "Kavout | AI", "count": 1}, {"label": "Via Ritzau", "count": 1}, {"label": "Macau Business", "count": 1}, {"label": "Caixin Global", "count": 1}, {"label": "TradingView", "count": 1}, {"label": "StockInvest.us", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 11}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 10}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "92/100 classification confidence."}, {"label": "Company focus", "value": "11", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-6.6% over one week, +16.7% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Shanghai Junshi Biosciences Co., Ltd. Receives Acceptance Of Supplemental Application For Toripalimab In Combination With Chemotherapy As Perioperative Treatment For Resectable Stage II-III NSCLC Patients"}], "updated_at": "2026-07-22T01:40:19.056451+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}